Delivery Order SPE2DB20D3103-SPE2DB23FP4Y1

Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,778 potassium chloride extended-release tablets in packages of 500. The contract has a ceiling value of $1,349.95 and a completion date of April 17, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles, with a potential value of $1,217.67 and a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,198.85 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500 count bottles. The contract has an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Chloride Extended Release 8 MEQ Tablets in quantities of 500s. The $2,346.33 firm fixed-price delivery order was placed against Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,700.69 fixed-price delivery order is for the supply of 4561232349 potassium chloride extended-release 8 MEQ tablets in 500-count bottles. The contract has a June 14, 2023 completion date and was awarded on June 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,876.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 per bottle. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through March 4, 2025. No set-aside designation was used for this award. Amerisourcebergen...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,273.14 firm-fixed-price delivery order is for the supply of 4,564,602,240 units of Potassium Chloride 10% (20 MEQ/15 ML) in 15 ML cups. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,730.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of potassium chloride extended-release tablets, a medication used to treat potassium deficiency. This is a firm-fixed-price delivery order contract with a completion date of December 12, 2024. The contract is not associated with any set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The $1,391.28 firm-fixed-price delivery order has a completion date of September 15, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award, valued at $2,312.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4557624443 - Potassium Chloride Extended Release 20 MEQ Tablets, 500-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 24, 2022. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP4Y1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Potassium Chloride Extended Release 10 MEQ Tablets in quantities of 500 per bottle. The contract has a ceiling value of $1,199.60 and a period of performance through August 25, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

Generated 2/27/25, 11:43 AM